Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

12 Labours Kidney Epithelial model

ABSTRACT: Kidney epithelial model developed by Leyla Noroozbabaee (l.noroozbabaee@auckland.ac.nz).

SUBMITTER: David Nickerson

PROVIDER: 6b4 | Physiome Model Repository |

REPOSITORIES: PMR

ACCESS DATA

Json Xml

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets

Exome seuencing of tumors from PPM1D transgenic mouse model

Project description:Exome sequencing of lymphoma tumors developed in PPM1D transgenic mouse model after irradiation

| PRJEB40261 | ENA

National Cancer Institute - Patient Derived Model Repository

Project description:Patient-derived tumor xenografts developed by the National Cancer Institute's Patient Derived Model Repository (PDMR)

| PRJEB37099 | ENA

Genetic characterization of pharmacoresistance in an epilepsy mouse model

Project description:Characterization of the heritability and genetic factors underlying the differential response to antiseizure drugs (ASDs) in a newly developed mouse model of ASD resistance.

2022-06-19 | PRJEB53593 | EVA

CELA1 and AAT deficient murine model proteome

Project description:Chymotrypsin-like elastase 1 (CELA1) is a serine protease that is neutralized by alpha-1 antitrypsin (AAT) and prevents emphysema in a murine antisense oligonucleotide model of AAT-deficient emphysema. We tested the role of CELA1 in emphysema development in this genetic model of AAT-deficiency following tracheal lipopolysaccharide (LPS), 10 months of cigarette smoke (CS) exposure, aging, and a low-dose tracheal porcine pancreatic elastase (LD-PPE) model we developed. In this last model, we performed proteomic analysis to understand differences in lung protein composition. We were unable to show that AAT-deficient mice developed more emphysema than wild type with escalating doses of LPS.

2023-02-20 | MSV000091330 | MassIVE

NAFLD model

Project description:NAFLD model

| PRJNA371560 | ENA

Mouse small cell lung cancer model

2010-06-01 | GSE18534 | GEO

Intestinal model

Project description:Intestinal model Metagenome

| PRJNA453619 | ENA

Mouse small cell lung cancer model

Project description:A mouse model for human small cell lung carcinoma (SCLC) has been developed based on evidence in human tumors that the tumor suppressor functions of RB and p53 are defective in more than 90% of SCLC cases. We also developed another mouse model also combines loss of p130 (Rbl2), an RB-related gene, with deletion of RB and p53. These two mouse tumors were shown to closely resemble human SCLC. The goal of this array experiment is to assess genome-wide gene expression of those mouse tumors and determine the similarity of the mouse models to human SCLC. Gene expression from Mouse Rb/p53 ( n=10 ) and Rb/p53/p130 primary tumors ( n=3 ) as well as tumor-free adult mouse lungs ( n=2 ) was measured using the Affymetrix GeneChip Mouse Genome 430-2.0 arrays.

2010-06-08 | E-GEOD-18534 | biostudies-arrayexpress

AI Prediction Model and Risk Stratification for Lung Metastasis in Colorectal Cancer

Project description:Background: To assist clinicians with diagnosis and optimal treatment decision-making, we attempted to develop and validate an artificial intelligence prediction model for lung metastasis (LM) in colorectal cancer (CRC) patients. Method: The clinicopathological characteristics of 46037 CRC patients from the Surveillance, Epidemiology, and End Results (SEER) database and 2779 CRC patients from a multi-center external validation set were collected retrospectively. After feature selection by univariate and multivariate analyses, six machine learning (ML) models, including logistic regression, K-nearest neighbor, support vector machine, decision tree, random forest, and balanced random forest (BRF), were developed and validated for the LM prediction. The optimization model with best performance was compared to the clinical predictor. In addition, stratified LM patients by risk score were utilized for survival analysis.

| 46649 | ecrin-mdr-crc

Mouse HCC model

Project description:A mouse model of HCC has been developed based on the reported inactivation of the RB pathway in the majority of human HCC. This mouse model harbors floxed alleles of Rb and p130 genes, as well as germline mutation of the p107 gene. Various strategies to activate the activity of a Cre recombinase leads to the efficient deletion of the three genes in the liver of adult mice (TKO mice). Disruption of the RB pathway induces the rapid development of HCC. These HCCs share many similar features of human HCC. The goal of this array is to assess genome wide expression of TKO HCCs. Gene expression of control livers (n=4) or TKO HCCs (n=5) was measured using the Affymetrix GeneChip Mouse Genome 430-2.0 arrays

2010-07-30 | E-GEOD-19004 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data